West Pharma (WST) Stock Leads S&P 500 Rout with 38% Slump
West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...
Is WST Stock Undervalued At $200?
Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...
StockStory.org on MSN1d
Why West Pharmaceutical Services (WST) Stock Is Nosediving
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...
West Pharmaceutical forecasts 2025 results below expectations, shares drop
West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...
S&P 500 Gains and Losses Today: MGM Stock Surges as Macau, Digital Businesses Thrive
The S&P 500 advanced 1.0% on Thursday, Feb. 13, as an executive order deferred the possible implementation of reciprocal ...
These Stocks Moved the Most Today: Trade Desk, AppLovin, Intel, Tesla, Robinhood, Deere, MGM, West Pharma, and More
Trade Desk sinks following a revenue miss, AppLovin surges after quarterly revenue soars 44%, and Intel extends the stock’s ...
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...
Why West Pharmaceutical Services, Inc. (WST) Went Down on Thursday
We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...
KeyBanc Sticks to Their Buy Rating for West Pharmaceutical Services (WST)
KeyBanc analyst Paul Knight maintained a Buy rating on West Pharmaceutical Services (WST – Research Report) today and set a price target of ...
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...